Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: SEVERITY OF ILLNESS INDEX - ADMINISTRATION AND DOSAGE , . Treffer: 6

2005

Galié, N; Badesch, D; Oudiz, R; Simonneau, G; McGoon, MD; Keogh, AM; Frost, AE; Zwicke, D; Naeije, R; Shapiro, S; Olschewski, H; Rubin, LJ Ambrisentan therapy for pulmonary arterial hypertension.
J Am Coll Cardiol. 2005; 46(3):529-535 Doi: 10.1016/j.jacc.2005.04.050 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2004

Pacifico, A; Fargnoli, MC; Cerroni, L; Peris, K Widespread recurrent lichenoid papular eruption--quiz case.
ARCH DERMATOL. 2004; 140(4): 479-484. Doi: 10.1001/archderm.140.4.479-c (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2003

Hermann, J; Mueller, T; Fahrleitner, A; Dimai, HP Early onset and effective inhibition of bone resorption in patients with rheumatoid arthritis treated with the tumour necrosis factor alpha antibody infliximab.
CLIN EXP RHEUMATOL 2003 21: 473-476.
Web of Science PubMed

 

Olschewski, H; Rohde, B; Behr, J; Ewert, R; Gessler, T; Ghofrani, HA; Schmehl, T Pharmacodynamics and pharmacokinetics of inhaled iloprost, aerosolized by three different devices, in severe pulmonary hypertension.
Chest. 2003; 124(4):1294-1304 Doi: 10.1378/chest.124.4.1294 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2001

Farup, PG; Hinterleitner, TA; Lukas, M; Hebuterne, X; Rachmilewitz, D; Campieri, M; Meier, R; Keller, R; Rathbone, B; Oddsson, E Mesalazine 4 g daily given as prolonged-release granules twice daily and four times daily is at least as effective as prolonged-release tablets four times daily in patients with ulcerative colitis.
Inflamm Bowel Dis. 2001; 7(3):237-242 Doi: 10.1097%2F00054725-200108000-00009
Web of Science PubMed FullText FullText_MUG

 

2000

Lépine, JP; Goger, J; Blashko, C; Probst, C; Moles, MF; Kosolowski, J; Scharfetter, B; Lane, RM A double-blind study of the efficacy and safety of sertraline and clomipramine in outpatients with severe major depression.
Int Clin Psychopharmacol. 2000; 15(5):263-271 Doi: 10.1097/00004850-200015050-00003
Web of Science PubMed FullText FullText_MUG

 

© Med Uni Graz Impressum